Stuart Therapeutics

0 followers


Stuart Therapeutics is a biotechnology company that offers PolyCol, a therapeutic platform for ophthalmic indications.

Industries

Headquarters

Stage

Employees

Links

Org chart

Eric Schlumpf
President & CEO

Eric Schlumpf

Collapse
Robert O. Baratta
Chairman, Chief Medical Officer & Head Product Development
David Calkins
Chief Science Officer
Shawn Delorey
EVP, Program Management